• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞舌尔群岛单危险因素与总体风险管理预防心血管事件的潜在影响。

Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles.

机构信息

Yale School of Public Health, New Haven, United States of America.

出版信息

Bull World Health Organ. 2011 Apr 1;89(4):286-95. doi: 10.2471/BLT.10.082370. Epub 2011 Feb 17.

DOI:10.2471/BLT.10.082370
PMID:21479093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3066521/
Abstract

OBJECTIVE

To assess the prevalence of cardiovascular (CV) risk factors in Seychelles, a middle-income African country, and compare the cost-effectiveness of single-risk-factor management (treating individuals with arterial blood pressure ≥ 140/90 mmHg and/or total serum cholesterol ≥ 6.2 mmol/l) with that of management based on total CV risk (treating individuals with a total CV risk ≥ 10% or ≥ 20%).

METHODS

CV risk factor prevalence and a CV risk prediction chart for Africa were used to estimate the 10-year risk of suffering a fatal or non-fatal CV event among individuals aged 40-64 years. These figures were used to compare single-risk-factor management with total risk management in terms of the number of people requiring treatment to avert one CV event and the number of events potentially averted over 10 years. Treatment for patients with high total CV risk (≥ 20%) was assumed to consist of a fixed-dose combination of several drugs (polypill). Cost analyses were limited to medication.

FINDINGS

A total CV risk of ≥ 10% and ≥ 20% was found among 10.8% and 5.1% of individuals, respectively. With single-risk-factor management, 60% of adults would need to be treated and 157 cardiovascular events per 100000 population would be averted per year, as opposed to 5% of adults and 92 events with total CV risk management. Management based on high total CV risk optimizes the balance between the number requiring treatment and the number of CV events averted.

CONCLUSION

Total CV risk management is much more cost-effective than single-risk-factor management. These findings are relevant for all countries, but especially for those economically and demographically similar to Seychelles.

摘要

目的

评估塞舌尔(一个中等收入的非洲国家)心血管(CV)危险因素的流行情况,并比较单一危险因素管理(治疗动脉血压≥140/90mmHg 和/或总血清胆固醇≥6.2mmol/L 的个体)与基于总 CV 风险的管理(治疗总 CV 风险≥10%或≥20%的个体)的成本效益。

方法

使用 CV 危险因素流行情况和非洲 CV 风险预测图来估计 40-64 岁人群中发生致命或非致命 CV 事件的 10 年风险。这些数据用于比较单一危险因素管理与总风险管理在需要治疗以避免一次 CV 事件的人数和 10 年内可能避免的事件数量方面的效果。对于高总 CV 风险(≥20%)的患者,假定治疗包括几种药物(复合药物)的固定剂量联合。成本分析仅限于药物治疗。

结果

分别有 10.8%和 5.1%的个体存在总 CV 风险≥10%和≥20%。采用单一危险因素管理,需要治疗的成年人比例为 60%,每年每 10 万人可避免 157 例心血管事件,而采用总 CV 风险管理,需要治疗的成年人比例为 5%,可避免 92 例心血管事件。基于高总 CV 风险的管理优化了需要治疗的人数和可避免的 CV 事件数量之间的平衡。

结论

总 CV 风险管理比单一危险因素管理更具成本效益。这些发现与所有国家都有关,但与那些在经济和人口方面与塞舌尔相似的国家尤为相关。

相似文献

1
Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles.塞舌尔群岛单危险因素与总体风险管理预防心血管事件的潜在影响。
Bull World Health Organ. 2011 Apr 1;89(4):286-95. doi: 10.2471/BLT.10.082370. Epub 2011 Feb 17.
2
Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.一个中等收入国家心血管危险因素的患病率及一种治疗策略的估计成本。
BMC Public Health. 2006 Jan 19;6:9. doi: 10.1186/1471-2458-6-9.
3
Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles.塞舌尔心血管疾病传统风险因素与心血管代谢风险因素的十五年分化趋势
Cardiovasc Diabetol. 2009 Jun 26;8:34. doi: 10.1186/1475-2840-8-34.
4
Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.固定剂量复方制剂在中国、印度、墨西哥、尼日利亚和南非用于心血管疾病二级预防的成本效益:一项建模研究。
Lancet Glob Health. 2019 Oct;7(10):e1346-e1358. doi: 10.1016/S2214-109X(19)30339-0. Epub 2019 Aug 30.
5
Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK.在英国使用复方制剂提高依从性对继发性心血管疾病预防的成本效益及公共卫生效益
BMJ Open. 2015 May 9;5(5):e007111. doi: 10.1136/bmjopen-2014-007111.
6
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.依洛尤单抗在西班牙心血管高危患者中的成本效益分析
Clin Ther. 2017 Apr;39(4):771-786.e3. doi: 10.1016/j.clinthera.2017.02.011. Epub 2017 Mar 31.
7
Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.固定剂量复方药丸(多效药丸)治疗对广泛的中度心血管疾病风险患者心血管相对风险降低的估计。
Eur J Prev Cardiol. 2016 Aug;23(12):1289-97. doi: 10.1177/2047487315624523. Epub 2016 Jan 7.
8
Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.类风湿关节炎患者的心血管风险管理仍不理想:类风湿关节炎心血管风险管理项目。
Rheumatology (Oxford). 2017 Sep 1;56(9):1472-1478. doi: 10.1093/rheumatology/kew497.
9
The social transition of risk factors for cardiovascular disease in the African region: evidence from three cross-sectional surveys in the Seychelles.非洲地区心血管疾病危险因素的社会转型:塞舌尔三项横断面调查的证据。
Int J Cardiol. 2013 Sep 30;168(2):1201-6. doi: 10.1016/j.ijcard.2012.11.064. Epub 2012 Nov 30.
10
Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.美国人群中发作性偏头痛患者基于弗雷明汉的心血管风险评估:美国偏头痛患病率和预防研究(AMPP)的结果。
Headache. 2017 Nov;57(10):1507-1521. doi: 10.1111/head.13179. Epub 2017 Oct 9.

引用本文的文献

1
A Cross-sectional Study on Prevalence of Cardiovascular Disease Risk among Hypertensive Patients Using the World Health Organization-International Society of Hypertension Chart in Rural Field Practice Areas of a Medical College, Chennai.在金奈一所医学院的农村实地实践地区,使用世界卫生组织 - 国际高血压学会图表对高血压患者心血管疾病风险患病率的横断面研究
J Midlife Health. 2025 Jul-Sep;16(3):267-271. doi: 10.4103/jmh.jmh_1_25. Epub 2025 Sep 5.
2
Prevalence of polypharmacy in heart failure patients: A retrospective cross-sectional study in a tertiary hospital in Saudi Arabia.沙特阿拉伯一家三级医院心力衰竭患者多重用药的患病率:一项回顾性横断面研究
Saudi Pharm J. 2023 Dec;31(12):101875. doi: 10.1016/j.jsps.2023.101875. Epub 2023 Nov 13.
3
Socioemotional Factors and Cardiovascular Risk: What Is the Relationship in Brazilian Older Adults?社会情感因素与心血管风险:巴西老年人中二者的关系是什么?
Innov Aging. 2023 Jul 26;7(7):igad078. doi: 10.1093/geroni/igad078. eCollection 2023.
4
Assessment of Total Cardiovascular Risk Using WHO/ISH Risk Prediction Chart Among Adults in Oman: A Nationally Representative Survey.使用WHO/ISH风险预测图表评估阿曼成年人的总体心血管风险:一项具有全国代表性的调查。
Oman Med J. 2023 May 31;38(3):e501. doi: 10.5001/omj.2023.70. eCollection 2023 May.
5
Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.固定剂量复方制剂(波利维)在心血管疾病一级和二级预防中的成本效益:系统文献回顾。
PLoS One. 2022 Jul 28;17(7):e0271908. doi: 10.1371/journal.pone.0271908. eCollection 2022.
6
Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study.基于实验室和非实验室的世界卫生组织心血管疾病风险图表比较:一项基于人群的研究。
J Transl Med. 2022 Mar 16;20(1):133. doi: 10.1186/s12967-022-03336-4.
7
Cardiovascular event risk estimation among residents of a rural setting in Bayelsa state, Nigeria.尼日利亚巴耶尔萨州农村地区居民心血管事件风险评估
Am J Cardiovasc Dis. 2021 Jun 15;11(3):300-315. eCollection 2021.
8
Hypertension Prevalence Based on Blood Pressure Measurements on Two vs. One Visits: A Community-Based Screening Programme and a Narrative Review.基于两次与一次就诊时血压测量的高血压患病率:社区筛查项目和叙述性综述。
Int J Environ Res Public Health. 2020 Dec 15;17(24):9395. doi: 10.3390/ijerph17249395.
9
Estimation of total cardiovascular risk using the 2019 WHO CVD prediction charts and comparison of population-level costs based on alternative drug therapy guidelines: a population-based study of adults in Bangladesh.采用 2019 年世卫组织 CVD 预测图表估算全因心血管风险,并基于替代药物治疗指南比较基于人群的成本:孟加拉国成年人的一项基于人群的研究。
BMJ Open. 2020 Jul 19;10(7):e035842. doi: 10.1136/bmjopen-2019-035842.
10
Predictors of Smoking Cessation in a Lifestyle-Focused Text-Message Support Programme Delivered to People with Coronary Heart Disease: An Analysis From the Tobacco Exercise and Diet Messages (TEXTME) Randomised Clinical Trial.一项针对冠心病患者的以生活方式为重点的短信支持项目中戒烟的预测因素:来自烟草、运动与饮食信息(TEXTME)随机临床试验的分析
Tob Use Insights. 2020 Jan 28;13:1179173X20901486. doi: 10.1177/1179173X20901486. eCollection 2020.

本文引用的文献

1
Physician support for a population-based pharmaceutical approach to cardiovascular prevention: not there yet.医生对基于人群的心血管疾病预防药物治疗方法的支持:尚未实现。
Prev Med. 2011 Jan;52(1):18-9. doi: 10.1016/j.ypmed.2010.11.017. Epub 2010 Dec 2.
2
The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.预防心血管疾病的多效药丸:关键概念、现状、挑战及未来方向。
Circulation. 2010 Nov 16;122(20):2078-88. doi: 10.1161/CIRCULATIONAHA.109.873232.
3
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.接受复方药治疗方案以预防美国医生群体中的心血管疾病。
Prev Med. 2011 Jan;52(1):10-5. doi: 10.1016/j.ypmed.2010.09.016. Epub 2010 Oct 8.
4
Harnessing health IT for improved cardiovascular risk management.利用健康信息技术改善心血管风险管理。
PLoS Med. 2010 Aug 24;7(8):e1000313. doi: 10.1371/journal.pmed.1000313.
5
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.22 个国家缺血性卒中和脑出血的危险因素研究(INTERSTROKE 研究):一项病例对照研究。
Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.
6
Standards of medical care in diabetes--2010.《糖尿病医疗护理标准——2010》
Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc10-S011.
7
Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US.C反应蛋白升高对美国黑人和白人男性及女性心血管风险分层的影响。
Clin Chem. 2009 Sep;55(9):1627-36. doi: 10.1373/clinchem.2008.122093. Epub 2009 Jul 30.
8
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.他汀类药物对无心血管疾病但有心血管危险因素人群的益处:随机对照试验的荟萃分析。
BMJ. 2009 Jun 30;338:b2376. doi: 10.1136/bmj.b2376.
9
Predicting the 30-year risk of cardiovascular disease: the framingham heart study.预测心血管疾病的30年风险:弗雷明汉心脏研究
Circulation. 2009 Jun 23;119(24):3078-84. doi: 10.1161/CIRCULATIONAHA.108.816694. Epub 2009 Jun 8.
10
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.阿司匹林用于血管疾病的一级和二级预防:来自随机试验的个体参与者数据的协作荟萃分析
Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.